DRUGMATRIX assay tests CYP450 and 3A4 enzyme inhibition using a homologous single protein target assigned to 7-Benzyloxy-4-(trifluoromethyl)-coumarin substrate with assay cell type BTI-TN-5B1-4. The assay is in vitro and described as binding. Does the molecule work for this assay?